Executive Summary: CDDF Annual Conference 2026 – “Cancer Clinical Research in a Changing Global Environment” (9-11 Feb 2026)
The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of this year’s Annual Conference has been published today and is available to all our stakeholders. This multi-stakeholder conference took place on 9-11 February 2026 in...![[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]](https://cddf.org/wp-content/uploads/2026/02/202602_INNOVATIVE-ONCOLOGY-TRIAL-DESIGNS_TIME-TO-ACT-1080x675.jpg)
[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]
While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.” This paper was largely...
Key Takeaways of the CDDF ACT-EU Webinar Series
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent ACT-EU webinar series, “Collaborating with stakeholders to define priorities for clinical trials and working collectively to address them.” The first session was held on 15...
Key Takeaways of the CDDF Webinar : “Long-Term Outcomes of In-Utero Exposure to Cytotoxic Therapy.”
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent webinar, “Long-term outcomes of in-utero exposure to cytotoxic therapy.” This webinar was held on 4 December 2025 and featured insightful presentations from...